There is no single refrigerated shelf life that applies to every compounded tirzepatide vial. The practical answer depends on the dispensing pharmacy's beyond-use date, the stated storage conditions and any separate instructions after first use. A universal "28 to 60 days" chart cannot establish the lifetime of an unspecified preparation.
Read these dates separately
| Date or interval | What it describes | What to identify |
|---|---|---|
| Compounding date | When the preparation was made | The date on the dispensing record or label |
| Beyond-use date | The assigned limit for the specific compounded preparation | The actual vial's dated instructions and storage conditions |
| First-use interval | A separate interval, if specified, after opening or puncturing | The pharmacy's instructions for that presentation |
| Delivery date | When the shipment arrived | It is not automatically the compounding or first-use date |
The questions "how long since it was made?" and "how long since it was first used?" have different starting points. Refrigeration describes a storage condition; it does not by itself identify which date applies.
Why one vial's duration does not establish another's
A stability result concerns a particular preparation, container and set of storage conditions. To compare it with a vial, identify the formulation, concentration, container, temperature, observation period and method used to measure the result. A different formulation or container can make a superficially similar comparison incomplete.
A USP-hosted stability reference introduction describes stability studies as a resource for assigning or extending beyond-use dates, with several preparation-specific factors to evaluate. It is a technical resource introduction, not a published stability study of your tirzepatide vial or a universal tirzepatide expiry chart.
What a useful stability record contains
A relevant report identifies the exact preparation and the outcomes tested. Drug content over time, physical appearance and microbiological results are different kinds of observation. A clear liquid is not itself a measurement of the amount of active ingredient remaining.
Get compounded tirzepatide, first month $149, then $239 per month, or $214 per month with Subscribe & Save
Free provider review, personalized dosing, and ongoing support included.
Start Free Assessment →A statement such as "visual inspection catches 90% of stability failures" needs a study that defines those failures and measures detection against a reference method. Without such a study, the percentage does not establish a reliable inspection test. Likewise, a numbered degradation model needs actual measurements before it can supply a shelf-life prediction.
How to compare a label with an online shelf-life claim
Record the vial's named preparation, concentration, beyond-use date, storage conditions and first-use instructions together. Then ask whether an online source describes that same preparation and situation. Instructions for a branded pen, an unopened container or a different concentration are not interchangeable with a pharmacy's compounded vial record.
For example, "30 days after first use" and a dated beyond-use limit describe separate constraints. The first is a relative interval; the second is a calendar date. An online article cannot choose between them for an unidentified product, and a later delivery date does not reset either clock.
Frequently asked questions
Does every compounded tirzepatide vial last 60 days refrigerated?
No universal duration is established by the name of the active ingredient alone. The preparation-specific date and storage record are the relevant information.
Does the date start when the package arrives?
The delivery date and the compounding date are different events. A first-use interval also has its own starting event. The vial's instructions identify the applicable dates.
Can appearance show the remaining potency?
Appearance and measured drug content are different observations. A numerical potency claim needs an appropriate measurement, not just a photograph or a clear solution.
Can I copy a storage timeline from a branded tirzepatide pen?
That timeline describes the manufacturer's specific product and presentation. It does not independently establish stability for another formulation or container.
Related tirzepatide guides
Source
Stability Reference Document for Pharmaceutical Compounding: USP-hosted introduction.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly. Brand names are referenced for educational comparison only.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →